Suven Life Sciences Limited (BOM:530239)
India · Delayed Price · Currency is INR 130.00
-3.75 (-2.80%)
At close: Mar 27, 2026
Suven Life Sciences Market Cap
Suven Life Sciences has a market cap or net worth of 34.28 billion as of March 27, 2026. Its market cap has increased by 28.86% in one year.
Market Cap
34.28B
Enterprise Value
31.71B
Revenue
70.62M
Ranking
n/a
PE Ratio
n/a
Stock Price
130.00
Market Cap Chart
Since July 31, 2002, Suven Life Sciences's market cap has increased from 1.61B to 34.28B, an increase of 2,027.44%. That is a compound annual growth rate of 13.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 34.28B | -9.67% |
| Dec 31, 2025 | 37.95B | 35.97% |
| Dec 31, 2024 | 27.91B | 58.69% |
| Dec 29, 2023 | 17.59B | 17.75% |
| Dec 30, 2022 | 14.94B | 31.72% |
| Dec 31, 2021 | 11.34B | -1.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neuland Laboratories | 154.88B |
| Shilpa Medicare | 67.59B |
| Gujarat Themis Biosyn | 29.27B |
| IOL Chemicals and Pharmaceuticals | 23.09B |
| NGL Fine-Chem | 13.86B |
| Bajaj HealthCare | 9.90B |
| Anlon Healthcare | 6.17B |
| Shree Ganesh Remedies | 5.99B |